Improving cognition
The Down Syndrome Research and Treatment Foundation is dedicated to finding a treatment to improve cognition including learning, memory and speech for individuals with Down syndrome. Since our founding in 2004 we have become the leading private source of funding in the United States for Down syndrome cognition research. Read about our results.
May Webinar: Dr. Jon Pierce-Shimomura
May 22, 2012, 10 AM PT / 1 PM ET
We're pleased to welcome Dr. Jon Pierce-Shimomura of the University of Texas at Austin to our continuing series of webinars. Dr. Pierce-Shimomura, neurobiologist and parent of a child with Down syndrome, is conducting innovative research on Down syndrome and Alzheimer's disease using tiny worms to understand the neural degeneration that occurs with aging. Join us to hear his perspective on current research — register now.
Roche starts early-stage clinical trials
First potential therapy designed to improve cognition and adaptive behavior in individuals with Down syndrome
Roche, a leader in research-focused healthcare and the world’s largest biotech firm, announces the initiation of its first Phase 1, multi-site clinical trial to investigate the safety and tolerability of a molecule designed to address the cognitive and behavioral deficits associated with Down syndrome. Learn more about this groundbreaking endeavor.